Zhitong Finance App News, China Resources Pharmaceutical (03320.HK) announced that China Resources Pharmaceutical Commercial Group Co., Ltd. (China Resources Pharmaceutical Commercial), a non-wholly-owned subsidiary of the company, proposed issuing new shares through public bidding through legally established equity exchanges in accordance with the relevant provisions of the “Measures for the Supervision and Administration of State-owned Assets Transactions of Enterprises”. On October 16, 2026, pre-bid procedures relating to the potential offering were initiated through the Beijing Equity Exchange. On October 16, 2026, China Resources Pharmaceutical Commercial published a pre-disclosure application for capital increase information on pre-bid procedures on the Beijing Equity Exchange website.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.